Protagenic Therapeutics, Inc. logo

Protagenic Therapeutics, Inc. (PTIX)

Market Closed
17 Jul, 20:00
OTC PINK OTC PINK
$
0. 26
0
0%
$
470.65K Market Cap
- P/E Ratio
- Div Yield
3,032 Volume
0 Eps
$ 0.26
Previous Close
Investors:
Add Transaction
Day Range
0.26 0.26
Year Range
0.14 6.2
Want to track PTIX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Protagenic Therapeutics, Inc. (PTIX) Statistics

Valuation metrics

Market Cap 470.65K
Enterprise value 1.41M
Trailing P/E (ttm) -0.08
Forward P/E -
PEG ratio 0
Price/Sales (ttm) -
Price/Book (mrq) -0.21
Enterprise Value/Revenue -
Enterprise Value/EBITDA -0.18

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.3K
Average volume (90 days) 9.5K

Price summary

52-Week low 0.14
52-Week high 6.2
Beta -
50-Day moving average 0.35
200-Day moving average 0.55

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 2 Dec 2005
Ex-Dividend Date 5 Dec 2005
Last split factor 1:14
Last split Date 5 May 2025

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin -
Operating margin -

Operational effectiveness

Return on assets -2.42%
Return on equity 1.85%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.66
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 1.14
Total debt (mrq) -
Total Debt/Equity (mrq) -1.32
Current ratio (mrq) 0.34%
Book value per share (mrq) -2.42

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -